Clinical studies using Bruin Biometrics’ OrthoSonos device show promising trends in the detection of early stage osteoarthritis (OA) that could lead to better treatments. OrthoSonos is being revealed to a select group of physicians at an invite-only event during AAOS on March 13th.
Help employers find you! Check out all the jobs and post your resume.